Our rapid drug testing product portfolio was developed to deliver exclusive configurations that test for the most relevant drugs of abuse. In the height of America’s prescription drug epidemic and rise in synthetic opioids, our configurations include tests for these prescription pain pills and other relevant drugs of abuse. We understand the unique needs of our clients and the variations of their markets throughout the country.
Customization Is Particularly Important
Premier Biotech recognizes that our customer needs vary based on their industry, and drug abuse trends differ throughout each state and region. We look to continually bring new development in drug testing to market, ensuring rapid product customization including options for drug panels at various cut-off levels.
Not All Drug Testing Products Are Created Equal
Our goal is to provide customers with a solution to identify the presence of drugs that are not detected in most rapid panels. Many organizations that are running drug testing programs still utilize their dated panel options that are years old. Why is this a concern? It’s simple, most traditional 5 panel tests detect the standard drugs common among rapid configurations: AMP, THC, COC, OPI, PCP. With many other newer drugs being abused including synthetic opioids, it is imperative that testing programs are monitored and revised.
With the goal of workplace safety and employee health, drugs of abuse testing has proven to be an effective deterrent to illicit drug use and abuse by workers. Premier Biotech Labs, LLC and its affiliated company, Premier Biotech has years of experience in providing testing options to the workplace environment.
Premier Biotech understands that test results are used to make key decisions such as compliance with parole or probation violation of rules pertaining to incarceration and personal recognizance. We strive to provide accurate, reliable and defensible drug testing results in a time sensitive manner.
Relevant Drugs To Round Out Your Testing Menu
A semisynthetic opioid derivative of thebaine. It is a mixed partial agonist opioid receptor modulator that is used to treat opioid addiction in higher dosages, to control moderate acute pain in non-opioid-tolerant individuals in lower dosages and to control moderate chronic pain in even smaller doses.
Fentanyl is a powerful synthetic opiate analgesic similar to but more potent than morphine. It is typically used to treat patients with severe pain, or to manage pain after surgery. It is also sometimes used to treat people with chronic pain who are physically tolerant to opiates. It is a schedule II prescription drug.
Synthetic marijuana is a designer drug in which herbs or other leafy materials are sprayed with lab-synthesized liquid chemicals that mimic the effect of (THC), the psychoactive ingredient in the naturally grown marijuana plant (cannabis sativa). This drug first became available in the U.S. in 2008
A semi-synthetic opioid with a structural similarity to codeine. It produces potent euphoria, analgesic and sedative effects, and has a dependence liability similar to morphine. Oxycodone is most often administered orally and is metabolized by demethylation to noroxycodone and oxymorphone followed by glucuronidation.
Tramadol is the generic name for a prescription pain reliever sold under the brand names Ultram, Conzip, Rybix ODT, and Ultram ER. Doctors prescribe Tramadol to treat moderate to severe pain. Due to the current drug epidemic, Tramadol is being abused more due to it’s inexpensive cost on the street.
Field Drug Test Kits Available
NARK® II drug identification pouches have the capability of presumptively identifying several families of substances suspected of being abused drugs. Designed to function as a transportable narcotics laboratory, NARK® II pouches are available for use wherever the need for their capability might arise. Each of the tests is comprised of one or more chemical reagents.
Industry Leading Drug Testing Solutions
Premier Biotech, Inc.
723 Kasota Avenue SE
Minneapolis, MN 55414
Premier Biotech Labs
©2017 Premier Biotech, Inc. All Rights Reserved.